Vimarsana
Biggest News Aggregation in the World

Page 3 - Lymphoma Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lymphoma Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lymphoma Program Today - Breaking & Trending Today

Research roundup: Recent grants and publications for Emory faculty and staff - Vimarsana News

Research roundup: Recent grants and publications for Emory faculty and staff

A summary of recent publications and grants from Emory faculty, students and staff

Source: emory.edu
Spatial profiling predicts recurrence of Hodgkin lymphoma after bone marrow transplant - Vimarsana News

Spatial profiling predicts recurrence of Hodgkin lymphoma after bone marrow transplant

Cedars-Sinai Cancer investigators have discovered a new way to predict whether a cancer of the immune system will recur in patients treated with a bone marrow transplant.

Dr Cohen on the Efficacy of Pirtobrutinib in High-Risk Patients With MCL - Vimarsana News

Dr Cohen on the Efficacy of Pirtobrutinib in High-Risk Patients With MCL

Jonathon B. Cohen, MD, MS, discusses safety and efficacy outcomes with pirtobrutinib in previously treated patients with relapsed/refractory mantle cell lymphoma, as observed in the phase 1/2 BRUIN study.

Pirtobrutinib Displays Activity in Relapsed/Refractory MCL Following Covalent BTK Inhibitor Therapy - Vimarsana News

Pirtobrutinib Displays Activity in Relapsed/Refractory MCL Following Covalent BTK Inhibitor Therapy

Pirtobrutinib demonstrated promising efficacy and a tolerable safety profile in heavily pretreated patients with relapsed/refractory mantle cell lymphoma who received prior therapy with a covalent BTK inhibitor.

Bio Ascend, a Vaniam Group Company, Reconvenes Inaugural Class of the "Academy of Next Wave of Investigators™" in CLL and NHL - Vimarsana News

Bio Ascend, a Vaniam Group Company, Reconvenes Inaugural Class of the "Academy of Next Wave of Investigators™" in CLL and NHL

/PRNewswire/ -- Bio Ascend, Vaniam Group's medical education company, this past weekend reconvened the inaugural class of its Academy of Next Wave of...